BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38786326)

  • 21. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
    Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
    J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
    Kim JY; Lee J; Koh JS; Park MJ; Chang UK
    J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of brachyury expression in chordomas.
    Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
    Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of immunotherapy in treatment refractory chordomas: review of current evidence.
    Alexander AY; Dhawan S; Venteicher AS
    Front Surg; 2024; 11():1375567. PubMed ID: 38881706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
    Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A
    Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.
    Gellner V; Tomazic PV; Lohberger B; Meditz K; Heitzer E; Mokry M; Koele W; Leithner A; Liegl-Atzwanger B; Rinner B
    Sci Rep; 2016 Apr; 6():24195. PubMed ID: 27072875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chordoma: the entity.
    Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
    Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathological features of notochordal tumors: a study of 48 cases].
    Huang J; Yang TT; Jiang ZM; Zhang HZ
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):201-206. PubMed ID: 33677882
    [No Abstract]   [Full Text] [Related]  

  • 32. DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment.
    Baluszek S; Kober P; Rusetska N; Wągrodzki M; Mandat T; Kunicki J; Bujko M
    Acta Neuropathol Commun; 2023 Jul; 11(1):113. PubMed ID: 37434245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors.
    Yoon JY; Jiang W; Orr CR; Rushton C; Gargano S; Song SJ; Modi M; Hozack B; Abraham J; Mallick AB; Brooks JSJ; Rosenbaum JN; Zhang PJ
    Cancer Genet; 2021 Nov; 258-259():74-79. PubMed ID: 34583232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
    Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
    Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
    Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
    J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between TBXT rs2305089 polymorphism and chordoma in Iranian patients identified by a developed T-ARMS-PCR assay.
    Jalessi M; Gholami MS; Razmara E; Hassanzadeh S; Sadeghipour A; Jahanbakhshi A; Tabibkhooei A; Bahrami E; Falah M
    J Clin Lab Anal; 2022 Jan; 36(1):e24150. PubMed ID: 34837714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
    Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
    Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
    Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
    Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish.
    D'Agati G; Cabello EM; Frontzek K; Rushing EJ; Klemm R; Robinson MD; White RM; Mosimann C; Burger A
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31221659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.